Skip to main content
logo
LIR Life Sciences Corp. (CSE:SKNY)
Canada flag Canada · Delayed Price · Currency is CAD
0.2200
0.00 (0.00%)
Oct 6, 2026, 12:16 PM EST

LIR Life Sciences Cash Flow Statement

Millions CAD. Fiscal year is May - Apr.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024
Period Ending
Jul '26 Apr '26 Apr '25 Apr '24
Net Income
-4.75-3.9-0.42-0.08
Depreciation & Amortization
00--
Asset Writedown & Restructuring Costs
0.10.1--
Stock-Based Compensation
1.991.59--
Other Operating Activities
0.330.33--
Change in Accounts Receivable
-0.02-0.01-0.03
Change in Accounts Payable
-0.1-0.060.170.11
Change in Other Net Operating Assets
0.06-0.11--
Operating Cash Flow
-2.39-2.04-0.250
Operating Cash Flow Growth
----

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024
Period Ending
Jul '26 Apr '26 Apr '25 Apr '24
Cash Acquisitions
1.521.52--
Sale (Purchase) of Intangibles
--0.11--
Investing Cash Flow
1.521.41--

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024
Period Ending
Jul '26 Apr '26 Apr '25 Apr '24
Short-Term Debt Issued
-0.040.06-
Total Debt Issued
0.010.040.060.58
Short-Term Debt Repaid
---0.26-
Total Debt Repaid
---0.26-
Net Debt Issued (Repaid)
0.010.04-0.190.58
Issuance of Common Stock
1.071.070.380
Repurchase of Common Stock
-0-0-0-
Other Financing Activities
-0-0-0.01-
Financing Cash Flow
1.071.10.170.58

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024
Period Ending
Jul '26 Apr '26 Apr '25 Apr '24
Net Cash Flow
0.20.48-0.070.59

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024
Period Ending
Jul '26 Apr '26 Apr '25 Apr '24
Levered Free Cash Flow
-0.91-0.92-0.09-
Unlevered Free Cash Flow
-0.91-0.92-0.09-

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024
Period Ending
Jul '26 Apr '26 Apr '25 Apr '24
Change in Working Capital
-0.07-0.170.180.08